Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Contact information


susan.wagland@ndorms.ox.ac.uk

Susan Wagland

BA, BSc, MSc, PhD

Clinical Trial Manager

Orthopaedic trauma

As Clinical Trials Manager in Oxford Trauma Group I am responsible for day-to-day management of clinical trials:

  • UKSTAR Study which is in recruitment;
  • PATH-2 Study which has met its recruitment target and is in follow-up;
  • AIM Trial, which has been published and is providing further data for analysis.

In UKSTAR we want to know whether patients with Achilles tendon ruptures treated non-surgically have a better outcome depending on whether they are immobilised in a plaster cast or an orthopaedic brace (walking boot). The PATH-2 study is investigating the effect of platelet rich plasma (PRP) as a non-surgical treatment for Achilles tendon ruptures, and the AIM Trial tested a new casting technique for ankle fractures treated without surgery. 

I have two years’ experience of clinical trial management, and prior to working for the University, I spent 15 years in the IT industry, and specialised in project management, data quality and release management. I have also worked in University administration.

During my scientific training, I worked on breast cancer and gained a PhD from Brunel University London in Biology and Biochemistry Research. I also hold a BSc (Hons) in Life Sciences from the Open University and a MSc from Brunel in Molecular Medicine with Cancer Research.